3Bolton C,Flower RJ.The effects of the anti-glucocorticoid RU38486 on steroid-mediated suppression of experimental allergic encephalomyelitis(EAE)in the Lewis rat[J].Life Sci,1989,45(1):97-104.
4Bolton C,Oneill JK,Allen SJ,et al.Regulation of chronic relapsing experimental allergic encephalomyelitis by endogenousand exogenous glucocorticoids[J].Int Arch Allergy Immunol,1997,114(4):74-80.
5Virley DJ.Developing therapeutics for the treatment of multiple sclerosis[J].The Journal of the American Society for Experimental Neuro Therapeutics.2005,2(4):638-649.
6Dhib-Jalbut S.Glatiramer acetate(Copaxonel)therapy for multiple sclerosis[J].Pharmacology & Therapeutics,2003,98(2):245-255.
7Farina C,Weber MS,Meinl E,et al.Glatiramer acetate in multiple sclerosis:update on potential mechanisms of action[J].Lancet Neurology,2005,4(9):567-575.
8Rovaris M,comi G,Filippi M.Can glatiramer acetate reduce brain atrophy development in multiple sclerosis?[J].Journal of the Neurological Sciences,2005,233(1-2):139-143.
9Liu C,Blumhardt LD.Benefits of glatiramer acetate on disability in relapsing-remitting multiple sclerosis:an analysis by area under disability/time curves[J].Journal of the Neurological Sciences,2000,181(1-2):33-37.
10Munari LM,Filippini G.Lack of evidence for use of glatiramer acetate in multiple sclerosis[J].The Lancet Neurology,2004,3(11):641.
